Avanos Medical (AVNS) moves to withdraw NYSE listing of its common stock
Rhea-AI Filing Summary
Avanos Medical, Inc. is removing its common stock from listing and registration on the New York Stock Exchange under Section 12(b) of the Securities Exchange Act of 1934. The exchange states it has complied with its own rules for striking the class of securities, and the company has complied with exchange rules and 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the common stock from listing and registration.
Positive
- None.
Negative
- None.
Key Terms
Section 12(b), Form 25, voluntary withdrawal, 17 CFR 240.12d2-2(c)
4 terms
Section 12(b) regulatory
"removal from listing and/or registration under Section 12(b) of the Securities Exchange Act"
Section 12(b) of the U.S. Securities Exchange Act requires securities listed on a national stock exchange to be registered with the U.S. Securities and Exchange Commission (SEC) and to follow regular public reporting and disclosure rules. For investors, a 12(b) listing generally means more routine financial updates, regulatory oversight and easier buying and selling—like a storefront that must display its inventory and prices, making it simpler to inspect and trade the product.
Form 25 regulatory
"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"
A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.
voluntary withdrawal regulatory
"governing the voluntary withdrawal of the class of securities from listing"
17 CFR 240.12d2-2(c) regulatory
"the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 25 filing mean for Avanos Medical (AVNS)?
The filing states that Avanos Medical’s common stock is being removed from listing and registration on the New York Stock Exchange under Section 12(b) of the Exchange Act.
Which Avanos Medical (AVNS) securities are affected by this action?
The action specifically concerns Avanos Medical, Inc. common stock. The document notes the removal of this class of securities from listing and registration on the New York Stock Exchange.
Is the Avanos Medical (AVNS) NYSE delisting described as voluntary?
Yes. The text cites 17 CFR 240.12d2-2(c), stating the issuer complied with exchange rules and that provision, which governs the voluntary withdrawal of a class of securities from listing and registration.
What role does the New York Stock Exchange play in the Avanos Medical (AVNS) delisting?
The New York Stock Exchange certifies that it has complied with its rules to strike the class of securities from listing and that it has reasonable grounds to file Form 25 on Avanos Medical’s common stock.
Which regulations are referenced in the Avanos Medical (AVNS) Form 25?
The filing references Section 12(b) of the Exchange Act and rules under 17 CFR 240.12d2-2, including subsection (c), which covers voluntary withdrawal of a security from listing and registration.